Patent details

EP3503884 Title: PHARMACEUTICAL COMPOSITION FOR USE IN TREATING PRURITUS AND/OR ITCH

Basic Information

Publication number:
EP3503884
PCT Application Number:
IB2017053989
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177455094
PCT Publication Number:
WO2018037295
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION FOR USE IN TREATING PRURITUS AND/OR ITCH
French Title of Invention:
COMPOSITION PHARMACEUTIQUE UTILISÉE POUR LE TRAITEMENT DU PRURIT ET/OU DES DÉMANGEAISONS
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR VERWENDUNG BEI DER BEHANDLUNG VON PRURITUS UND/ODER JUCKREIZ
SPC Number:

Dates

Filing date:
30/06/2017
Grant date:
21/07/2021
EP Publication Date:
03/07/2019
PCT Publication Date:
01/03/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/07/2021
EP B1 Publication Date:
21/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/06/2022
Expiration date:
30/06/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/07/2021
 
 

Name:
Neurim Pharmaceuticals Ltd.
Address:
27 HaBarzel Street, 6971039 Tel Aviv, Israel (IL)

Inventor

Name:
LAUDON, Moshe
Address:
Israel (IL)

Priority

Priority Number:
201662378435 P
Priority Date:
23/08/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/351; A61K 31/4045; A61P 17/04; A61K 31/404; A61K 45/06; A61K 9/00; A61K 9/06; A61K 47/22; A61K 47/24; A61K 47/26; A61K 47/36; A61K 47/38; A61K 47/44; A61K 47/46;

Publication

European Patent Bulletin

Issue number:
202129
Publication date:
21/07/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages